Tandem Diabetes Care, Inc. (TNDM) Net margin 2016–2025
Tandem Diabetes Care, Inc. (TNDM) net profit margin by fiscal year — reported net income divided by reported revenue.
-20.2%FY2025 · since FY2016: -99.0% → -20.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -20.2% | -10.0 pp |
| FY2024 | -10.2% | +19.6 pp |
| FY2023 | -29.8% | -18.0 pp |
| FY2022 | -11.8% | -14.0 pp |
| FY2021 | 2.2% | +9.1 pp |
| FY2020 | -6.9% | -0.1 pp |
| FY2019 | -6.8% | +59.9 pp |
| FY2018 | -66.7% | +1.2 pp |
| FY2017 | -67.9% | +31.2 pp |
| FY2016 | -99.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNDM financial trends
TNDM RevenueTNDM Net incomeTNDM Gross profitTNDM Gross marginTNDM Operating incomeTNDM Operating marginTNDM Operating cash flowTNDM Free cash flowTNDM Capital expendituresTNDM Return on equityTNDM Stock buybacksTNDM Dividends paidTNDM Total assetsTNDM Total liabilitiesTNDM Shareholders’ equityTNDM overview →